Lex­a­gene does not say why trad­ing vol­ume is up, but...

Stockwatch Daily - - HEALTH CARE - Dr. Jack Re­gan re­ports

AT THE re­quest of IIROC, Lex­a­gene Hold­ings Inc. con­firms that the com­pany’s man­age­ment is un­aware of any ma­te­rial change in the com­pany’s op­er­a­tions that would ac­count for the re­cent in­crease in mar­ket ac­tiv­ity.

The com­pany is still on track and ex­cited for com­plet­ing the LX6 Al­pha pro­to­type by the end of Novem­ber.

About Lex­a­Gene Hold­ings


Lex­a­Gene is a biotech­nol­ogy com­pany de­vel­op­ing the very first fully au­to­mated pathogen de­tec­tion plat­form that is ope n-ac­cess. The open-ac­cess fea­ture will em­power end users to tar­get any pathogen of in­ter­est, as they can load their own real-time PCR as­says onto the in­stru­ment for cus­tom­ized pathogen de­tec­tion. End-users sim­ply need to col­lect a sam­ple, load it onto the in­stru­ment with a sam­ple prepa­ra­tion car­tridge, and press and go. The in­stru­ment is ex­pected to of­fer ex­cel­lent sen­si­tiv­ity, speci­ficity, and breadth of pathogen de­tec­tion. The in­stru­ment will be able to process six sam­ples at a time, in an on-de­mand fash­ion, re­turn­ing re­sults in about one hour. The com­pany ex­pects to sell its tech­nol­ogy in the food safety, vet­eri­nary di­ag­nos­tics, water qual­ity mon­i­tor­ing, and aqua­cul­ture pathogen sur­veil­lance mar­kets.

We seek Safe Har­bor.

Manohar Fur­tado, Eric Olsen, Daryl Michael Re­beck, John F Re­gan, Tom Slezak

(LXG) Shares: 51,676,833

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.